Zobrazeno 1 - 10
of 4 038
pro vyhledávání: '"Sheng Cheng"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-18 (2024)
Abstract This paper discusses the seismic performance of five reduced-scale shear walls, including one cast-in-place (CIP) concrete shear wall, two precast concrete (PC) shear walls with overlapping U-bar loop connections, and two PC shear walls with
Externí odkaz:
https://doaj.org/article/450db0a665f44d3ca8e392311014f350
Autor:
Bo Han, Daqing Cheng, Huizhao Luo, Jutang Li, Jiaoxiang Wu, Xing Jia, Ming Xu, Peng Sun, Sheng Cheng
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract Hepatocellular carcinoma (HCC) still presents poor prognosis with low overall survival rates and limited therapeutic options available. Recently, attention has been drawn to peptidomic analysis, an emerging field of proteomics for the explor
Externí odkaz:
https://doaj.org/article/0a5117f129784fa2a27f313308fbb634
Publikováno v:
MedComm, Vol 5, Iss 10, Pp n/a-n/a (2024)
Abstract Organoids are miniature, highly accurate representations of organs that capture the structure and unique functions of specific organs. Although the field of organoids has experienced exponential growth, driven by advances in artificial intel
Externí odkaz:
https://doaj.org/article/caee0d44519941c19930778401cd50ce
Autor:
Sheng Cheng, Yumei Wang
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
Drawing from the conservation of resources theory, this study proposes that individuals who perceive environmental competitiveness may improve their mental health through their job crafting behaviors at work. Data were collected from 450 full-time Ch
Externí odkaz:
https://doaj.org/article/cd4343bcd69543c08bbab09264954882
Publikováno v:
Heliyon, Vol 10, Iss 14, Pp e34834- (2024)
Clear Cell Renal Cell Carcinoma (ccRCC), the most prevalent form of renal cell carcinoma (RCC), poses a significant threat to human health due to its rising morbidity and mortality rates. Sunitinib, a pivotal targeted drug for the treatment of ccRCC,
Externí odkaz:
https://doaj.org/article/70ca67ccfadf46ddb4108d5088e27905
Autor:
Peng Gao, Huaixu Li, Yang Qiao, Jianyu Nie, Sheng Cheng, Guozhang Tang, Xingliang Dai, Hongwei Cheng
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e32270- (2024)
DLAT has been recognized as a cuproptosis-related gene that is crucial for cuproptosis in earlier research. The study is to look at how DLAT affects individuals with low-grade glioma's prognosis and immune infiltration. The Genotype-Tissue Expression
Externí odkaz:
https://doaj.org/article/b973f44fbdbf455e9748cc622d1c81d1
Autor:
Ze Li, Xiaozhen Wang, Dandan Li, Sheng Cheng, Zhe Li, Heng Guo, Yiwen Dong, Yingming Zheng, Xingang Li
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Purpose This study aimed to investigate the association between cytochrome P450 (CYP) 3A4*22 and cytochrome P450 oxidoreductase (POR)*28 variations and the pharmacokinetics of tacrolimus. Methods Cochrane Central Register of Controlled Trial
Externí odkaz:
https://doaj.org/article/dbd52a3e554f47ee8280b6a397a20f2f
Publikováno v:
Zeitschrift für Kristallographie - New Crystal Structures, Vol 239, Iss 1, Pp 73-75 (2024)
C16H9BrINO2, triclinic, P1̄ (no. 2), a = 7.9305(12) Å, b = 8.2051(10) Å, c = 11.3141(13) Å, α = 85.384(10)°, β = 85.619(11)°, γ = 87.745(11)°, V = 731.27(17) Å3, Z = 2, Rgt(F) = 0.0397, wRref(F2) = 0.0819, T = 293(2) K.
Externí odkaz:
https://doaj.org/article/8be68ecad9e647a6b1428c4c7ed59022
Autor:
Zixuan Chen, Cunzhou Wang, Yuesong Cai, An Xu, Chengtao Han, Yanjun Tong, Sheng Cheng, Min Liu
Publikováno v:
Biomolecules, Vol 14, Iss 8, p 1043 (2024)
Purpose: This study aims to explore the potential mechanisms of esculin in the treatment of renal cell carcinoma (RCC). Methods: We employed network pharmacology to predict the potential mechanisms and targets of esculin in RCC. Molecular docking tec
Externí odkaz:
https://doaj.org/article/99f34b37631b40dfa2144df4826007a4
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Introduction The optimal first-line immunotherapy regimen for advanced non-squamous non-small cell lung cancer (NS-NSCLC) patients with programmed cell death ligand 1 (PD-L1) expression ≥ 50% remains unclear. Our aim is to determine the mo
Externí odkaz:
https://doaj.org/article/e0351466e20844bdacf90b847354cc82